These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 36453273)

  • 21. Managing cardiovascular risk in people living with HIV in Asia - where are we now?
    Choi JY; Lui GCY; Liao CT; Yang CJ
    HIV Med; 2022 Feb; 23(2):111-120. PubMed ID: 34494350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation burden score in multidrug-resistant HIV-1 infection.
    Clemente T; Caccia R; Galli L; Galli A; Poli A; Marchetti GC; Bandera A; Zazzi M; Santoro MM; Cinque P; Castagna A; Spagnuolo V;
    J Infect; 2023 May; 86(5):453-461. PubMed ID: 36913985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection.
    McLaughlin MM; Ma Y; Scherzer R; Rahalkar S; Martin JN; Mills C; Milush J; Deeks SG; Hsue PY
    JAMA Netw Open; 2020 Oct; 3(10):e2018099. PubMed ID: 33119103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating biomarker correlates of left atrial size and myocardial extracellular volume fraction among persons living with and without HIV.
    Peterson TE; Landon C; Haberlen SA; Bhondoekhan F; Plankey MW; Palella FJ; Piggott DA; Margolick JB; Brown TT; Post WS; Wu KC
    BMC Cardiovasc Disord; 2022 Sep; 22(1):393. PubMed ID: 36057773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives.
    Fragkou PC; Moschopoulos CD; Dimopoulou D; Triantafyllidi H; Birmpa D; Benas D; Tsiodras S; Kavatha D; Antoniadou A; Papadopoulos A
    Hellenic J Cardiol; 2023; 71():42-54. PubMed ID: 36646212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.
    Kaplan-Lewis E; Aberg JA; Lee M
    Curr HIV/AIDS Rep; 2016 Oct; 13(5):297-308. PubMed ID: 27562769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
    Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
    Front Immunol; 2019; 10():289. PubMed ID: 30846990
    [No Abstract]   [Full Text] [Related]  

  • 28. Human Immunodeficiency Virus as a Risk Factor for Cardiovascular Disease.
    Lembas A; Załęski A; Peller M; Mikuła T; Wiercińska-Drapało A
    Cardiovasc Toxicol; 2024 Jan; 24(1):1-14. PubMed ID: 37982976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.
    De Lorenzo F; Collot-Teixeira S; Boffito M; Feher M; Gazzard B; McGregor JL
    Curr Med Chem; 2008; 15(28):2991-9. PubMed ID: 19075647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Low Frequency of IL-17-Producing CD8
    Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
    Front Immunol; 2018; 9():2502. PubMed ID: 30420859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals.
    Nkambule BB; Davison GM; Ipp H
    Int J Lab Hematol; 2015 Aug; 37(4):450-8. PubMed ID: 25401263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aortic aneurysms and markers of platelet activation, hemostasis, and endothelial disruption in people living with HIV.
    Grønbæk SK; Høgh J; Knudsen AD; Pham MHC; Sigvardsen PE; Fuchs A; Kühl JT; Køber L; Gerstoft J; Benfield T; Ostrowski SR; Kofoed KF; Nielsen SD
    Front Immunol; 2023; 14():1115894. PubMed ID: 36817421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selected inflammatory and coagulation biomarkers pre-viral suppression in people with human immunodeficiency virus (HIV) infection without overt cardiovascular disease: Is there a need to redefine reference indices?
    Louw S; Mayne ES; Jacobson BF; Mayne AL
    Cytokine; 2023 May; 165():156174. PubMed ID: 36996538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
    Nordell AD; McKenna M; Borges ÁH; Duprez D; Neuhaus J; Neaton JD; ;
    J Am Heart Assoc; 2014 May; 3(3):e000844. PubMed ID: 24870935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial mitochondrial senescence accelerates cardiovascular disease in antiretroviral-receiving HIV patients.
    Chen YF; Dugas TR
    Toxicol Lett; 2019 Dec; 317():13-23. PubMed ID: 31562912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated cardiac risk score by Atherosclerotic Cardiovascular Disease calculation is associated with albuminuria in older people living with HIV.
    Johnston CD; Ifeagwu KC; Siegler EL; Derry H; Burchett CO; Rice MC; Gupta SK; Choi ME; Glesby MJ
    AIDS; 2020 May; 34(6):947-949. PubMed ID: 32271253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacological management of cardiovascular disease in people living with HIV (PLWH).
    Corbacho N; Mur I; Molas ME; Vidal F; Domingo P
    Expert Opin Pharmacother; 2021 Apr; 22(6):743-753. PubMed ID: 33283570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda.
    North CM; Muyanja D; Kakuhikire B; Tsai AC; Tracy RP; Hunt PW; Kwon DS; Christiani DC; Okello S; Siedner MJ
    J Acquir Immune Defic Syndr; 2018 Aug; 78(5):543-548. PubMed ID: 29683991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bacterium
    Ouyang J; Lin J; Isnard S; Fombuena B; Peng X; Marette A; Routy B; Messaoudene M; Chen Y; Routy JP
    Front Immunol; 2020; 11():645. PubMed ID: 32328074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of Cardiovascular Disease in the Setting of HIV Infection.
    Hsue PY
    Can J Cardiol; 2019 Mar; 35(3):238-248. PubMed ID: 30825947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.